Current Good Manufacturing Practice for Finished Pharmaceuticals¶
U.S. Food and Drug Administration. (1978). Current Good Manufacturing Practice for Finished Pharmaceuticals.
Cited by¶
1 citation across 1 artifact.
Each citation links to the sentence it supports in the citing article.
Primes¶
- Quality Control
- Pharmaceuticals: Good Manufacturing Practice (GMP) batch testing, stability studies, contamination detection, potency assays, dissolution testing, microbial limits testing, finished-product release testing, as codified in the U.S. FDA's (1978) 21 CFR Part 211 regulation governing finished-pharmaceutical manufacturing.
This sourceU.S. Government Printing Office. Federal regulation governing pharmaceutical batch testing, stability studies, potency assays, microbial limits, and finished-product release testing under cGMP.
- Pharmaceuticals: Good Manufacturing Practice (GMP) batch testing, stability studies, contamination detection, potency assays, dissolution testing, microbial limits testing, finished-product release testing, as codified in the U.S. FDA's (1978) 21 CFR Part 211 regulation governing finished-pharmaceutical manufacturing.
Verification¶
This reference passed the adversarial substantiation pipeline: it was checked to exist and to support the claim it is attached to. See how references were verified.
Registry ID ref:96c62350da9d · see in the full table